Back
Catalyst Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
A 100% Win Rate In 2022
Click to see this exclusive sit-down interview
Buy
77
CPRX
Catalyst Pharmaceuticals
Last Price:
16.03
Seasonality Move:
12.04%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Get Free, Instant Access To Today's Top Stocks List!
View this list for FREE now!Catalyst Pharmaceuticals Price Quote
$16.03
-0.18 (-1.11%)
(Updated: March 23, 2023 at 4:10 PM ET)
Catalyst Pharmaceuticals Key Stats
Buy
77
Catalyst Pharmaceuticals (CPRX)
is a Buy
Day range:
$16.18 - $16.74
52-week range:
$6.15 - $22.11
Dividend yield:
0%
P/E ratio:
21.61
P/S ratio:
8.41
P/B ratio:
5.7%
Volume:
1.7M
Avg. volume:
1.8M
1-year change:
95.54%
Market cap:
$1.7B
Revenue:
$214.2M
EPS:
$0.74
How Much Does Catalyst Pharmaceuticals Make?
-
How Much Are Catalyst Pharmaceuticals's Sales Annually?
CPRX Revenues are $214.2M -
How Much Profit Does Catalyst Pharmaceuticals's Make A Year?
CPRX net income is $83.1M
Is Catalyst Pharmaceuticals Growing As A Company?
-
What Is Catalyst Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.59% -
What Is Catalyst Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 1.44%
Catalyst Pharmaceuticals Stock Price Performance
-
Did Catalyst Pharmaceuticals Stock Go Up Last Month?
Catalyst Pharmaceuticals share price went up by 5.4% last month -
Did CPRX's Share Price Rise Over The Last Year?
CPRX share price rose by 95.54% over the past 1 year
What Is Catalyst Pharmaceuticals 52-Week High & Low?
-
What Is Catalyst Pharmaceuticals’s 52-Week High Share Price?
Catalyst Pharmaceuticals has traded as high as $22.11 over the past 52 weeks -
What Is Catalyst Pharmaceuticals’s 52-Week Low Share Price?
Catalyst Pharmaceuticals has traded as low as $6.15 over the past 52 weeks
Catalyst Pharmaceuticals Price To Free Cash Flow
-
Is Catalyst Pharmaceuticals Stock Overvalued?
Catalyst Pharmaceuticals is trading at a price to free cash flow ratio of 15.53 -
Is Catalyst Pharmaceuticals Stock Undervalued?
Catalyst Pharmaceuticals EV to Free Cash Flow ratio is 12.19 -
What Is Catalyst Pharmaceuticals’s Price Earnings Growth Ratio?
CPRX PEG ratio is 0.22 -
Is Catalyst Pharmaceuticals Trading At A Premium To Earnings?
Catalyst Pharmaceuticals EV to EBIT ratio is 13.89
Is It Risky To Buy Catalyst Pharmaceuticals?
-
How Much Debt Does Catalyst Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Catalyst Pharmaceuticals Have?
Cash and short term investments quarterly total is $298.4M -
What Is Catalyst Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.85
Is Catalyst Pharmaceuticals Cash Flow Positive?
-
What Is CPRX Cash Flow From Operations?
Cash flow from operations (TTM) is $116M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.7M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $9.2M
Catalyst Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CPRX return on invested capital is 33.54% -
What Is Catalyst Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 28.44% -
What Is CPRX Return On Equity?
ROE is a measure of profitability and is 33.54%
Catalyst Pharmaceuticals Earnings Date & Stock Price
-
What Is Catalyst Pharmaceuticals's Stock Price Today?
A single share of CPRX can be purchased today for 16.21 -
What Is Catalyst Pharmaceuticals’s Stock Symbol?
Catalyst Pharmaceuticals trades on the nasdaq under the ticker symbol: CPRX -
When Is Catalyst Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Catalyst Pharmaceuticals is scheduled on May 10, 2023 -
When Is CPRX's next ex-dividend date?
Catalyst Pharmaceuticals's next ex-dividend date is May 30, 2020 -
How To Buy Catalyst Pharmaceuticals Stock?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Catalyst Pharmaceuticals Competitors
-
Who Are Catalyst Pharmaceuticals's Competitors?
Below is a list of companies who compete with Catalyst Pharmaceuticals or are related in some way:
Catalyst Pharmaceuticals Dividend Yield
Data Unavailable
Catalyst Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 144.44% | 11.86% |
| Revenue: | 58.6% | 0.19% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 21.65 |
| Upside from Last Price: | 33.56% |